Skip to content

Clinical trials

Myeloproliferative Disorders trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Sweden Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20141
20151
20192
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Ariad Pharmaceuticals1
Celgene1
Incyte Corporation1
John Mascarenhas1
Karolinska University Hospital1
Novartis Pharmaceuticals1
Sierra Oncology LLC - a GSK company1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders9
Hematologic Diseases4
Bone Marrow Diseases3
Neoplasms3
Primary Myelofibrosis3
Leukemia2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid2
Myelodysplastic Syndromes2
Neoplasms by Histologic Type2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.